EP1311684A1
Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 8 August 2021, 5.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
53 members in 9 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 634238 | United States of America | – | |
| 63423800 | United States of America | A | |
| 724623 | United States of America | – | |
| 72462300 | United States of America | A | |
| 0100160 | New Zealand | W |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| CA2263824A1 | Canada | A1 | |
| WO9808965A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4036797A | Australia | A | |
| WO9808965A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5912168A | United States of America | A | |
| EP0956358A2 | European Patent Office (EPO) | A2 | |
| NZ334359A | New Zealand | A | |
| JP2000517183A | Japan | A | |
| WO0113516A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6633800A | Australia | A | |
| AU732766B2 | Australia | B2 | |
| WO0113516A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2416982A1 | Canada | A1 | |
| WO0212506A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8455801A | Australia | A | |
| EP1206836A2 | European Patent Office (EPO) | A2 | |
| WO0244363A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0244383A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1649902A | Australia | A | |
| AU1650002A | Australia | A | |
| US2002151063A1 | United States of America | A1 | |
| US2002159976A1 | United States of America | A1 | |
| US6476209B1 | United States of America | B1 | |
| US6544772B1 | United States of America | B1 | |
| EP1311684A1This record | European Patent Office (EPO) | A1 | |
| US2003138822A1 | United States of America | A1 | |
| US2004009490A1 | United States of America | A1 | |
| JP2004505632A | Japan | A | |
| CA2501958A1 | Canada | A1 | |
| WO2004031389A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003278624A1 | Australia | A1 | |
| EP1206836B1 | European Patent Office (EPO) | B1 | |
| AT267480T | Austria | T | |
| ATE267480T1 | Austria | T1 | |
| DE60010899D1 | Germany | D1 | |
| US2004252755A1 | United States of America | A1 | |
| NZ526078A | New Zealand | A | |
| NZ523995A | New Zealand | A | |
| DE60010899T2 | Germany | T2 | |
| EP1546338A1 | European Patent Office (EPO) | A1 | |
| NZ534397A | New Zealand | A | |
| EP1311684A4 | European Patent Office (EPO) | A4 | |
| JP2006500951A | Japan | A | |
| EP1546338A4 | European Patent Office (EPO) | A4 | |
| US7026463B2 | United States of America | B2 | |
| NZ536894A | New Zealand | A | |
| US2006099623A1 | United States of America | A1 | |
| US7052896B2 | United States of America | B2 | |
| US7125698B2 | United States of America | B2 | |
| US2006251635A1 | United States of America | A1 | |
| AU2001284558B2 | Australia | B2 | |
| US2007004666A1 | United States of America | A1 | |
| US7489725B2 | United States of America | B2 |
8 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1311684
- Application
- 19636265
Titles3
- German
- LACTOBACILLUS RHAMNOSUS POLYNUKLEOTIDE, POLYPEPTIDE UND METHODEN ZU DEREN VERWENDUNG
- English
- LACTOBACILLUS RHAMNOSUS POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS FOR USING THEM
- French
- POLYNUCLEOTIDES ET POLYPEPTIDES LACTOBACILLUS RHAMNOSUS ET METHODES D'UTILISATION
Classification
- CPC, 21
- C12N9/00
- A23C19/0323
- A23C2220/202
- A61K38/00
- A61K39/00
- A61K2039/52
- A61K2039/53
- C07K14/335
- C07K2319/00
- A61P1/04
- A61P1/10
- A61P1/12
- A61P1/16
- A61P25/28
- A61P31/04
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/08
- A61P39/02
- A61P43/00
- IPC, 43
- G01N33 53
- A23C9 12
- A23C19 032
- A23L3 3463
- A61K35 74
- A61K38 00
- A61K38 44
- A61K39 00
- A61K48 00
- A61P1 04
- A61P1 10
- A61P1 12
- A61P1 16
- A61P25 28
- A61P31 04
- A61P35 00
- A61P37 00
- A61P37 02
- A61P37 08
- A61P39 02
- A61P43 00
- C07K14 335
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- C12N9 02
- C12N9 04
- C12N9 10
- C12N9 12
- C12N9 14
- C12N9 16
- C12N9 38
- C12N9 52
- C12N9 88
- C12N9 90
- C12N15 09
- C12N15 31
- C12Q1 68
- G01N33 566
- G01N33 58
- G01N37 00
Designated states26
- Contracting states, 20
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye
- Extension states, 6
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania
- Slovenia